Report - ANEXO I RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTOec.europa.eu/health/documents/community-register/1999/199912083344/... · história de encefalopatia hiperamonémica. 4.2 Posologia

Please pass captcha verification before submit form